JAZZ - Jazz Pharmaceuticals PLC Qarzning balans kapitallashuviga nisbati

Jazz Pharmaceuticals (JAZZ) onkologiya va og'ir uyqu buzilishlari uchun noyob retseptbo'y dori vositalarini sotish orqali daromad keltiradi. Generik dori vositalarining asta-sekin paydo bo'lishiga qaramay, bemorlarning sinalgan dori vositalariga sodiqligi barqaror kapital oqimini ta'minlaydi. Yuqori biznes masshtablanishi va tor nishalardagi narx belgilash imkoniyati kompaniyaga 0.94 ko'rsatkichiga erishish imkonini beradi. GURU.Markets platformasidagi ushbu narx harakati grafigi ushbu biofarmatsevtika ishtirokchisining moliyaviy barqarorligini aniq tasdiqlaydi.

JAZZ (Jazz Pharmaceuticals Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

Jazz Pharmaceuticals PLC (JAZZ) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:

Aksiya narxi Jazz Pharmaceuticals|JAZZ - Tahlilchilar konsensus prognozi

- bozor kapitallashuvi bo'yicha ma'lumotlar:

Bozor qiymati Jazz Pharmaceuticals Corp|JAZZ - Qarz va naqd pullar hisobga olingan qiymat

- balans kapitallashuvi bo'yicha ma'lumotlar:

Bitta aksiya uchun sof aktivlar Jazz Pharmaceuticals|JAZZ - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati jazzpharma.com|JAZZ - Kompaniyaning umumiy aktivlari

- qarz va likvidlik bo'yicha ma'lumotlar:

Umumiy qarzning xususiy kapitalga nisbati Jazz Pharmaceuticals|JAZZ - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Jazz Pharma|JAZZ - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Jazz Pharmaceuticals Corp

Kompaniyaning fundamental tahlili:Jazz Pharmaceuticals - JAZZ

Onkologiya patentlari va FDA ning qat'iy nazorati bilan himoyalangan Jazz Pharmaceuticals (JAZZ) uchun kompaniyaning balans hisoboti kapitaliga nisbatan qarz yuklamasi kengayish va moliyaviy barqarorlik o'rtasidagi muvozanatni aks ettiradi. Ushbu ko'rsatkich umumiy majburiyatlarni kapital bilan solishtiradi, bunda koeffitsiyentning pasayishi tolov qobiliyatining oshishi va defolt xatarlarining kamayishini anglatib, biznesning fundamental xavfsiz boshpanasini tasdiqlaydi.

Jazz Pharmaceuticals (JAZZ) raqobatchilari

Balans kapitallashuviga qarzlar CYTK (Cytokinetics)|ptcbio.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Scholar Rock Holding Corporation (SRRK)|CNTA: Qarzning sof aktivlarga nisbati|DYN (Dyne Pharma) - Qarzning balans kapitallashuviga nisbati|Edgewise Corp (EWTX) - Qarzning balans qiymatiga nisbati|RAPP (Rapport Therapeutics, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alumis.com (ALMS)|Zevra Therapeutics, Inc. (ZVRA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati CTNM (Contineum Therapeutics Inc)|LRMR - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Capricor Therapeutics Inc. CAPR|TRDA (Entrada Therapeutics) - Balans kapitallashuviga qarzlar|channeltherapeutics.com (PTHS) - Balans qiymatiga qarzlar|MNOV: Qarzning balans qiymatiga nisbati|SER (Serina Therapeutics Inc) - Balans kapitallashuviga qarzlar|BTAI - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PMN|Apimeds Pharmaceuticals - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar AEON (aeonbiopharma.com)|Qarzning balans kapitallashuviga nisbati NLS Pharmaceutics NLSP|Bionomics Ltd. - Qarzning balans kapitallashuviga nisbati|HUGE (FSD Pharma) - Qarzning balans kapitallashuviga nisbati|RETA - Balans qiymatiga qarzlar